Basic mechanisms of generalized absence seizures
- PMID: 7847856
- DOI: 10.1002/ana.410370204
Basic mechanisms of generalized absence seizures
Abstract
Generalized absence seizures are neurophysiologically, pharmacologically, and developmentally unique and comprise the primary seizure type in a number of different absence epilepsy syndromes. Over the last 10 years, the availability of a number of animal models of generalized absence seizures and of sophisticated in vitro electrophysiological techniques that allow investigation of cortical and thalamic networks has begun to shed light on the pathogenesis of this disorder. The basic underlying mechanism appears to involve thalamocortical circuitry and the generation of abnormal oscillatory rhythms from that particular neuronal network. Biochemical mechanisms operative within thalamocortical circuitry during this neuronal oscillation seem to entail phase-locked gamma-aminobutyric acid (GABA)B-mediated inhibition alternating with glutamate-mediated excitation. The basic cellular mechanism operative within this tension between excitation and inhibition appears to involve the T-type calcium current. Local circuitry within the thalamus may influence these oscillatory rhythms by GABAA-mediated inhibition. Pharmacological factors at play external to thalamocortical circuitry include cholinergic, dopaminergic, and noradrenergic mechanisms. Pathways that utilize these various neurotransmitters project onto the thalamus and/or cortex from sites distant to those structures and may modulate the process either up or down. Perturbation of one or more of these neuronal networks may lead to abnormal neuronal oscillatory rhythms within thalamocortical circuitry, with a resultant generation of bilaterally synchronous spike wave discharges that characterize generalized absence seizures. Our increasing understanding of the basic mechanisms that underlie generalized absence seizures promises to allow, for the first time, a rational design of drug treatment for a seizure disorder based on the pathogenesis of that disorder.
Similar articles
-
Typical versus atypical absence seizures: network mechanisms of the spread of paroxysms.Epilepsia. 2007 Aug;48(8):1585-93. doi: 10.1111/j.1528-1167.2007.01120.x. Epub 2007 May 1. Epilepsia. 2007. PMID: 17484751
-
Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy.Epilepsy Res. 2006 Sep;71(1):1-22. doi: 10.1016/j.eplepsyres.2006.05.012. Epub 2006 Jun 19. Epilepsy Res. 2006. PMID: 16787741 Review.
-
Evolving concepts on the pathophysiology of absence seizures: the cortical focus theory.Arch Neurol. 2005 Mar;62(3):371-6. doi: 10.1001/archneur.62.3.371. Arch Neurol. 2005. PMID: 15767501 Review.
-
Neuronal circuitry of thalamocortical epilepsy and mechanisms of antiabsence drug action.Adv Neurol. 1999;79:991-9. Adv Neurol. 1999. PMID: 10514881 Review.
-
Generalized epilepsy with bilateral synchronous spike and wave discharge. New findings concerning its physiological mechanisms.Electroencephalogr Clin Neurophysiol Suppl. 1978;(34):245-9. Electroencephalogr Clin Neurophysiol Suppl. 1978. PMID: 108073
Cited by
-
Distinct effects of the basal ganglia and cerebellum on the thalamocortical pathway in idiopathic generalized epilepsy.Hum Brain Mapp. 2021 Aug 1;42(11):3440-3449. doi: 10.1002/hbm.25444. Epub 2021 Apr 8. Hum Brain Mapp. 2021. PMID: 33830581 Free PMC article.
-
Myoclonus and other jerky movement disorders.Clin Neurophysiol Pract. 2022 Oct 6;7:285-316. doi: 10.1016/j.cnp.2022.09.003. eCollection 2022. Clin Neurophysiol Pract. 2022. PMID: 36324989 Free PMC article. Review.
-
Stargazer--a mouse to seize!Epilepsy Curr. 2005 Sep-Oct;5(5):161-5. doi: 10.1111/j.1535-7511.2005.00051.x. Epilepsy Curr. 2005. PMID: 16175212 Free PMC article.
-
The generation mechanism of spike-and-slow wave discharges appearing on thalamic relay nuclei.Sci Rep. 2018 Mar 21;8(1):4953. doi: 10.1038/s41598-018-23280-y. Sci Rep. 2018. PMID: 29563579 Free PMC article.
-
Branched-Chain Amino Acids and Seizures: A Systematic Review of the Literature.CNS Drugs. 2019 Aug;33(8):755-770. doi: 10.1007/s40263-019-00650-2. CNS Drugs. 2019. PMID: 31313139
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources